- Home
- Publications
- Publication Search
- Publication Details
Title
Bladder cancer
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1038/s41572-023-00468-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- KDM6A loss triggers an epigenetic switch that disrupts urothelial differentiation and drives cell proliferation in bladder cancer
- (2023) Hong Qiu et al. CANCER RESEARCH
- High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
- (2023) Jeroen van Dorp et al. NATURE MEDICINE
- Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer
- (2023) Emil Christensen et al. CLINICAL CANCER RESEARCH
- Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials
- (2023) Pramit Khetrapal et al. EUROPEAN UROLOGY
- Transurethral en bloc resection versus standard resection of bladder tumour: A multi-center randomized trial (EB-StaR Study)
- (2023) Y.C.J. Teoh et al. EUROPEAN UROLOGY
- Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort
- (2023) Peter S. Kirk et al. JOURNAL OF UROLOGY
- Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
- (2023) Alexandre R Zlotta et al. LANCET ONCOLOGY
- Y chromosome loss in cancer drives growth by evasion of adaptive immunity
- (2023) Hany A. Abdel-Hafiz et al. NATURE
- Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature
- (2023) Daniel D. Joyce et al. PHARMACOECONOMICS
- Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin
- (2023) Florus C. de Jong et al. Science Translational Medicine
- Diagnostic accuracy of bimanual palpation in bladder cancer patients undergoing cystectomy: A prospective study
- (2023) Anna K. Czech et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Identifying novel biomarkers associated with bladder cancer treatment outcomes
- (2023) Peris R. Castaneda et al. Frontiers in Oncology
- Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer
- (2023) Sophia C. Kamran et al. CLINICAL CANCER RESEARCH
- Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer
- (2023) Trine Strandgaard et al. EUROPEAN UROLOGY
- Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma
- (2023) Thomas Powles et al. EUROPEAN UROLOGY
- Repeat Transurethral Resection for Non–muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era
- (2023) Takafumi Yanagisawa et al. European Urology Focus
- En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial
- (2023) David D'Andrea et al. European Urology Oncology
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics for African American/Black People 2022
- (2022) Angela N. Giaquinto et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage
- (2022) Adithya Balasubramanian et al. WORLD JOURNAL OF UROLOGY
- The Paris System for Reporting Urinary Cytology: A Meta-Analysis
- (2022) Ilias P. Nikas et al. Journal of Personalized Medicine
- Development, regeneration and tumorigenesis of the urothelium
- (2022) Gregory B. Wiessner et al. DEVELOPMENT
- Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria
- (2022) Bhavan P. Rai et al. EUROPEAN UROLOGY
- Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma
- (2022) Petros Grivas et al. EUROPEAN UROLOGY
- Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer
- (2022) James W. F. Catto et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial
- (2022) Christian Pfister et al. JOURNAL OF CLINICAL ONCOLOGY
- Sex differences in bladder cancer: emerging data and call to action
- (2022) Dan Theodorescu et al. Nature Reviews Urology
- Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action
- (2022) Xiaochen Dai et al. TOBACCO CONTROL
- Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients
- (2022) Sungyong You et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy
- (2022) Zihai Li et al. Cancer Discovery
- Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
- (2022) Jianya Huan et al. Cancers
- Androgen conspires with the CD8 + T cell exhaustion program and contributes to sex bias in cancer
- (2022) Hyunwoo Kwon et al. Science Immunology
- Urinary Markers for Bladder Cancer Diagnosis and Monitoring
- (2022) Seung-Hwan Jeong et al. Frontiers in Cell and Developmental Biology
- DNA Damage and Oxidative Stress of Tobacco Smoke Condensate in Human Bladder Epithelial Cells
- (2022) Medjda Bellamri et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancer
- (2022) Francesco Soria et al. CURRENT OPINION IN UROLOGY
- Discoidin domain receptor-driven gene signatures as markers of patient response to anti-PD-L1 immune checkpoint therapy
- (2022) Sungyong You et al. JNCI-Journal of the National Cancer Institute
- NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
- (2022) Thomas W. Flaig et al. Journal of the National Comprehensive Cancer Network
- The dynamic roles of the bladder tumour microenvironment
- (2022) Yu-Cheng Lee et al. Nature Reviews Urology
- Bladder cancer, inflammageing and microbiomes
- (2022) Austin Martin et al. Nature Reviews Urology
- Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality
- (2022) Soichi Sano et al. SCIENCE
- The origin of bladder cancer from mucosal field effects
- (2022) Jolanta Bondaruk et al. iScience
- LBA76 Overall survival (OS) results from the phase III TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physician's choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC)
- (2022) H.S. Rugo et al. ANNALS OF ONCOLOGY
- Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer
- (2022) Trine Strandgaard et al. EUROPEAN UROLOGY
- Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy
- (2022) Laura S. Mertens et al. EUROPEAN UROLOGY
- Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
- (2022) Christopher J. Hoimes et al. JOURNAL OF CLINICAL ONCOLOGY
- Current best practice for bladder cancer: a narrative review of diagnostics and treatments
- (2022) Eva Compérat et al. LANCET
- The Legacy of RTOG/NRG Protocols in Shaping Current Bladder Preservation Therapy in North America
- (2022) Sophia C. Kamran et al. SEMINARS IN RADIATION ONCOLOGY
- Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy
- (2022) Anthony M. Magliocco et al. JAMA Network Open
- Robotic-assisted Versus Laparoscopic Versus Open Radical Cystectomy—A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
- (2022) Karl-Friedrich Kowalewski et al. European Urology Focus
- Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
- (2021) Min Yuen Teo et al. BRITISH JOURNAL OF CANCER
- Lynch Syndrome: Its Impact on Urothelial Carcinoma
- (2021) Andrea Katharina Lindner et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The effects of tobacco control policies on global smoking prevalence
- (2021) Luisa S. Flor et al. NATURE MEDICINE
- Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
- (2021) Gillian Vandekerkhove et al. Nature Communications
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Androgen Receptor Regulates CD44 Expression in Bladder Cancer
- (2021) Joseph L Sottnik et al. CANCER RESEARCH
- A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695)
- (2021) Thomas W. Flaig et al. CLINICAL CANCER RESEARCH
- Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes
- (2021) James W.F. Catto et al. EUROPEAN UROLOGY
- Finasteride Use and Risk of Bladder Cancer in a Multiethnic Population
- (2021) Denzel Zhu et al. JOURNAL OF UROLOGY
- Complications and Outcomes of Salvage Cystectomy after Trimodality Therapy
- (2021) Alberto Pieretti et al. JOURNAL OF UROLOGY
- Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
- (2021) Joaquim Bellmunt et al. LANCET ONCOLOGY
- Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma
- (2021) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies
- (2021) Massimiliano Creta et al. Diagnostics
- The IDENTIFY Study: The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study
- (2021) Sinan Khadhouri et al. BJU INTERNATIONAL
- Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing
- (2021) Li Wang et al. CLINICAL CANCER RESEARCH
- TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
- (2021) Scott T. Tagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting
- (2021) Jeremy Yuen-Chun Teoh et al. WORLD JOURNAL OF UROLOGY
- An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
- (2021) Sia Viborg Lindskrog et al. Nature Communications
- Perioperative Outcomes of Robot-Assisted Radical Cystectomy with Intracorporeal Versus Extracorporeal Urinary Diversion
- (2021) Jeremy Yuen-Chun Teoh et al. ANNALS OF SURGICAL ONCOLOGY
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
- (2021) Marko Babjuk et al. EUROPEAN UROLOGY
- Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
- (2021) Thomas Powles et al. LANCET ONCOLOGY
- Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
- (2021) Arjun V Balar et al. LANCET ONCOLOGY
- Hepatic Clearance of Cell-Free DNA: Possible Impact on Early Metastasis Diagnosis
- (2021) Sonia Khier et al. Molecular Diagnosis & Therapy
- ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
- (2021) Thomas Powles et al. NATURE
- Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
- (2021) Dean F. Bajorin et al. NEW ENGLAND JOURNAL OF MEDICINE
- TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer
- (2021) Neeraj Agarwal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer
- (2021) Kenneth H. Gouin et al. Nature Communications
- The Inequality of Females in Bladder Cancer
- (2021) Josephine M. Hyldgaard et al. APMIS
- Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes
- (2021) Gottfrid Sjödahl et al. EUROPEAN UROLOGY
- NRG Oncology/RTOG 0926: Phase II Protocol for Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
- (2021) D.M. Dahl et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells
- (2021) Laia Richart et al. NUCLEIC ACIDS RESEARCH
- Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
- (2021) Laura S. Mertens et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Impact of Androgen Suppression Therapy on the Risk and Prognosis of Bladder Cancer: A Systematic Review and Meta-Analysis
- (2021) Peng Xiang et al. Frontiers in Oncology
- Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019
- (2021) Saeid Safiri et al. BMJ Global Health
- Determinants of Resistance to Checkpoint Inhibitors
- (2020) Linda Tran et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) Thomas W. Flaig et al. Journal of the National Comprehensive Cancer Network
- The repertoire of mutational signatures in human cancer
- (2020) Ludmil B. Alexandrov et al. NATURE
- Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living
- (2020) Ellen Heitzer et al. TRENDS IN MOLECULAR MEDICINE
- Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome
- (2020) Artur Mezheyeuski et al. Scientific Reports
- European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
- (2020) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers
- (2020) Milena Matuszczak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer
- (2020) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- The Learning Curve for Transurethral Resection of Bladder Tumour: How Many is Enough to be Independent, Safe and Effective Surgeon?
- (2020) Sławomir Poletajew et al. Journal of Surgical Education
- Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
- (2020) Matthew D Galsky et al. LANCET
- Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes
- (2020) Joshua J. Meeks et al. Nature Reviews Urology
- Medical Care Costs Associated with Cancer Survivorship in the United States
- (2020) Angela B. Mariotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
- (2020) David A. Palma et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic accuracy of multiparametric MRI for local staging of bladder cancer: A systematic review and meta-analysis
- (2020) Suzan W.E. Cornelissen et al. UROLOGY
- Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer
- (2020) Joaquim Bellmunt et al. CANCER RESEARCH
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
- (2020) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of UTX/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer
- (2020) Douglas Barrows et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extensive heterogeneity in somatic mutation and selection in the human bladder
- (2020) Andrew R. J. Lawson et al. SCIENCE
- Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
- (2020) Ann Taber et al. Nature Communications
- Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer
- (2020) Marc A. Furrer et al. European Urology Focus
- Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
- (2020) Stephen A Boorjian et al. LANCET ONCOLOGY
- Partial cystectomy for muscle-invasive bladder cancer: a review of the literature
- (2020) Taylor C. Peak et al. Translational Andrology and Urology
- Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy
- (2020) Megan M. Tu et al. Communications Biology
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy
- (2019) Megan M. Tu et al. Science Advances
- Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients
- (2019) Arnold Degboe et al. SUPPORTIVE CARE IN CANCER
- Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
- (2019) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- Tumor associated macrophages promote bladder tumor growth through PI 3k/ AKT signal induced by collagen
- (2019) Shi Qiu et al. CANCER SCIENCE
- APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer
- (2019) Ming-Jun Shi et al. EUROPEAN UROLOGY
- Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
- (2019) Emil Christensen et al. JOURNAL OF CLINICAL ONCOLOGY
- A Nationwide Population Based Analysis of Organ-Confined Muscle-Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy in Sweden from 1997 to 2014.
- (2019) Dan-Olle Westergren et al. JOURNAL OF UROLOGY
- Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling
- (2019) Xingbo Long et al. Cell Death & Disease
- The Tumor Immune Microenvironment Drives a Prognostic Relevance that Correlates with Bladder Cancer Subtypes
- (2019) Carolin Pfannstiel et al. Cancer Immunology Research
- Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
- (2019) Yohann Loriot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urothelial cell carcinoma of the bladder in pediatric patients: a systematic review and data analysis of the world literature
- (2019) M.E. Rezaee et al. Journal of Pediatric Urology
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder
- (2019) Julio Calvete et al. HUMAN PATHOLOGY
- Preoperative imaging for locoregional staging of bladder cancer
- (2019) S. Mojdeh Mirmomen et al. Abdominal Radiology
- Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG Unresponsive Trials
- (2019) Max Kates et al. CLINICAL CANCER RESEARCH
- Sex Differences in Urothelial Bladder Cancer Survival
- (2019) Cecilia Radkiewicz et al. Clinical Genitourinary Cancer
- Large Single Institution Comparison of Perioperative Outcomes and Complications of Open Radical Cystectomy, Intracorporeal Robot-Assisted Radical Cystectomy and Robotic Extracorporeal Approach
- (2019) JJ H. Zhang et al. JOURNAL OF UROLOGY
- The global burden of urinary bladder cancer: an update
- (2019) Anke Richters et al. WORLD JOURNAL OF UROLOGY
- Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging?
- (2019) Sandeep Gurram et al. Current Urology Reports
- Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial
- (2019) Robert A. Huddart et al. EUROPEAN UROLOGY
- Why Y? Down-regulation of chromosome Y genes potentially contributes to elevated cancer risk
- (2019) Derek W Brown et al. JNCI-Journal of the National Cancer Institute
- Non-canonical Roles of Telomerase: Unraveling the Imbroglio
- (2019) Evelyne Ségal-Bendirdjian et al. Frontiers in Cell and Developmental Biology
- Machine learning and medicine: book review and commentary
- (2018) Robert Koprowski et al. Biomedical Engineering Online
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups
- (2018) Kim E.M. van Kessel et al. CLINICAL CANCER RESEARCH
- ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer
- (2018) Qiang Li et al. CLINICAL CANCER RESEARCH
- Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)
- (2018) Valeria Panebianco et al. EUROPEAN UROLOGY
- Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
- (2018) Sumit Isharwal et al. HUMAN PATHOLOGY
- Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer
- (2018) David J. Vaughn et al. JOURNAL OF CLINICAL ONCOLOGY
- Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
- (2018) Manish R Patel et al. LANCET ONCOLOGY
- Unravelling disparate roles of NOTCH in bladder cancer
- (2018) Akihiro Goriki et al. Nature Reviews Urology
- Diagnostic Accuracy of F-18 FDG PET/CT for Preoperative Lymph Node Staging in Newly Diagnosed Bladder Cancer Patients: A Systematic Review and Meta-Analysis
- (2018) Hong Ku Ha et al. ONCOLOGY
- Finasteride does not prevent bladder cancer: A secondary analysis of the Medical Therapy for Prostatic Symptoms Study
- (2018) Niranjan J. Sathianathen et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy
- (2018) Mohamed S. Zaghloul et al. JAMA Surgery
- X chromosome protects against bladder cancer in females via aKDM6A-dependent epigenetic mechanism
- (2018) Satoshi Kaneko et al. Science Advances
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer
- (2018) Li Wang et al. Nature Communications
- Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
- (2018) Jürgen E. Gschwend et al. EUROPEAN UROLOGY
- Safeguarding Autonomy of Patients With Bladder Cancer
- (2018) Divya Yerramilli et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712—A Randomized Phase II Trial
- (2018) John J. Coen et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer
- (2018) David T Miyamoto et al. LANCET ONCOLOGY
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- The Y chromosome: a blueprint for men’s health?
- (2017) Akhlaq A Maan et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
- (2017) Nicholas J. Giacalone et al. EUROPEAN UROLOGY
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
- (2017) Roland Seiler et al. EUROPEAN UROLOGY
- Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
- (2017) Lars Dyrskjøt et al. EUROPEAN UROLOGY
- Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
- (2017) Vishal Vashistha et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Holmium YAG Photocoagulation: Safe and Economical Alternative to Transurethral Resection in Small Nonmuscle-Invasive Bladder Tumors
- (2017) Jorge Planelles Gómez et al. JOURNAL OF ENDOUROLOGY
- Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
- (2017) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
- (2017) Sam S. Chang et al. JOURNAL OF UROLOGY
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
- (2017) Arjun V Balar et al. LANCET ONCOLOGY
- Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
- (2017) Padmanee Sharma et al. LANCET ONCOLOGY
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis
- (2017) Zijie Wang et al. Oncotarget
- Bladder cancer
- (2017) Oner Sanli et al. Nature Reviews Disease Primers
- The Paris System for Reporting Urinary Cytology
- (2016) Güliz A. Barkan et al. ADVANCES IN ANATOMIC PATHOLOGY
- Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer
- (2016) Mario I. Fernández et al. BJU INTERNATIONAL
- Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
- (2016) Jakob Hedegaard et al. CANCER CELL
- Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
- (2016) Philippe Lamy et al. CANCER RESEARCH
- Economic Burden of Bladder Cancer Across the European Union
- (2016) Jose Leal et al. EUROPEAN UROLOGY
- Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study
- (2016) Edwin E. Morales et al. EUROPEAN UROLOGY
- Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa–pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
- (2016) Richard J. Sylvester et al. EUROPEAN UROLOGY
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
- (2016) Jakub Dobruch et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
- (2016) Peter A. Humphrey et al. EUROPEAN UROLOGY
- Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder Cancer
- (2016) Brian C. Baumann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer
- (2016) Kimberley S. Mak et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy
- (2016) Brian C. Baumann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer
- (2016) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score–Weighted Analysis From the National Cancer Data Base
- (2016) Thomas Seisen et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response
- (2016) M L Nickerson et al. ONCOGENE
- A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer
- (2016) Linda S. Yang et al. SURGICAL ONCOLOGY-OXFORD
- ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis
- (2016) HOUGUANG HE et al. Oncology Letters
- Clinical Validation of Chemotherapy Response BiomarkerERCC2in Muscle-Invasive Urothelial Bladder Carcinoma
- (2016) David Liu et al. JAMA Oncology
- Microscopic haematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer
- (2015) Daniel Ramirez et al. BJU INTERNATIONAL
- Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
- (2015) Matthew D. Galsky et al. CANCER
- Mutation of theTERTpromoter, switch to active chromatin, and monoallelicTERTexpression in multiple cancers
- (2015) Josh Lewis Stern et al. GENES & DEVELOPMENT
- Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
- (2015) Cora N Sternberg et al. LANCET ONCOLOGY
- Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: A prospective, randomized study
- (2015) Yansheng Xu et al. LASERS IN SURGERY AND MEDICINE
- TERTpromoter mutations and telomerase reactivation in urothelial cancer
- (2015) Sumit Borah et al. SCIENCE
- Prediction of Druggable Proteins Using Machine Learning and Systems Biology: A Mini-Review
- (2015) Gaurav Kandoi et al. Frontiers in Physiology
- Concurrent Alterations in TERT, KDM6A, and the BRCA Pathway in Bladder Cancer
- (2014) M. L. Nickerson et al. CLINICAL CANCER RESEARCH
- Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis
- (2014) Aiye Guo et al. CUAJ-Canadian Urological Association Journal
- The quality of life in patients during intravesical treatment and correlation with local symptoms
- (2014) Li Wei et al. JOURNAL OF CHEMOTHERAPY
- Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233
- (2014) Raymond H. Mak et al. JOURNAL OF CLINICAL ONCOLOGY
- Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer
- (2014) Lars A Forsberg et al. NATURE GENETICS
- The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
- (2014) Christina Yeung et al. PHARMACOECONOMICS
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smoking is associated with mosaic loss of chromosome Y
- (2014) J. P. Dumanski et al. SCIENCE
- Micropapillary bladder cancer: Current treatment patterns and review of the literature
- (2014) Daniel L. Willis et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
- (2014) E. M. Van Allen et al. Cancer Discovery
- Mutational Context and Diverse Clonal Development in Early and Late Bladder Cancer
- (2014) Iver Nordentoft et al. Cell Reports
- Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis
- (2014) A. Richard et al. Andrology
- Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
- (2013) Richard K. Lee et al. BJU INTERNATIONAL
- Evaluation of urovysion and cytology for bladder cancer detection
- (2013) Haythem Dimashkieh et al. CANCER CYTOPATHOLOGY
- High-Resolution Profiling of Fetal DNA Clearance from Maternal Plasma by Massively Parallel Sequencing
- (2013) S. C. Y. Yu et al. CLINICAL CHEMISTRY
- Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
- (2013) Yves Allory et al. EUROPEAN UROLOGY
- Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes
- (2013) Claire F. Taylor et al. HUMAN MOLECULAR GENETICS
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- A Cell of Origin Gene Signature Indicates Human Bladder Cancer Has Distinct Cellular Progenitors
- (2013) Garrett M. Dancik et al. STEM CELLS
- Plasticity of In Vitro-Generated Urothelial Cells for Functional Tissue Formation
- (2013) Felix Wezel et al. TISSUE ENGINEERING PART A
- Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder
- (2012) Hiroshi Miyamoto et al. BJU INTERNATIONAL
- Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
- (2012) C. D. Hurst et al. CLINICAL CANCER RESEARCH
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Bladder cancer, a review of the environmental risk factors
- (2012) Silvia Letašiová et al. Environmental Health
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
- (2012) Jorg Oddens et al. EUROPEAN UROLOGY
- Oncogenic FGFR3 gene fusions in bladder cancer
- (2012) Sarah V. Williams et al. HUMAN MOLECULAR GENETICS
- RhoGDI2 suppresses lung metastasis in mice by reducing tumor versican expression and macrophage infiltration
- (2012) Neveen Said et al. JOURNAL OF CLINICAL INVESTIGATION
- CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma
- (2012) Sandra Rebouissou et al. JOURNAL OF PATHOLOGY
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
- (2012) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms
- (2012) Darren C. Tomlinson et al. PLoS One
- Extravasation of Intravesical Chemotherapy for Non-Muscle-Invasive Bladder Cancer
- (2012) Laura S. Mertens et al. UROLOGIA INTERNATIONALIS
- Association of secondhand smoke exposures with DNA methylation in bladder carcinomas
- (2011) Charlotte S. Wilhelm-Benartzi et al. CANCER CAUSES & CONTROL
- Association Between Smoking and Risk of Bladder Cancer Among Men and Women
- (2011) Neal D. Freedman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
- (2011) Maria De Santis et al. JOURNAL OF CLINICAL ONCOLOGY
- A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
- (2011) Matthew D Galsky et al. LANCET ONCOLOGY
- HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization
- (2011) Christina B Ching et al. MODERN PATHOLOGY
- Altered Splicing of FGFR1 Is Associated with High Tumor Grade and Stage and Leads to Increased Sensitivity to FGF1 in Bladder Cancer
- (2010) Darren C. Tomlinson et al. AMERICAN JOURNAL OF PATHOLOGY
- Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt
- (2010) Shady Salem et al. BJU INTERNATIONAL
- LIFE AND DEATH OF SPARE (SELECTIVE BLADDER PRESERVATION AGAINST RADICAL EXCISION): REFLECTIONS ON WHY THE SPARE TRIAL CLOSED
- (2010) Robert A. Huddart et al. BJU INTERNATIONAL
- Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical Trial
- (2010) Rauf Taner Divrik et al. EUROPEAN UROLOGY
- Micropapillary urothelial carcinoma of the urinary bladder: A clinicopathological analysis of 24 cases
- (2010) Neil Edgerton et al. INTERNATIONAL JOURNAL OF UROLOGY
- Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer
- (2010) Andrea B. Apolo et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers
- (2010) R. S. van der Post et al. JOURNAL OF MEDICAL GENETICS
- Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy
- (2010) Martine Ploeg et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Deoxyribonuclease Activity and Circulating DNA Concentration in Blood Plasma of Patients with Prostate Tumors
- (2009) Anna V. Cherepanova et al. Annals of the New York Academy of Sciences
- Bladder malignancies in children aged
- (2009) Shaheen Alanee et al. BJU INTERNATIONAL
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
- (2009) Per-Uno Malmström et al. EUROPEAN UROLOGY
- Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase–2 and –7 and E-cadherin
- (2009) Yasuyoshi Miyata et al. HUMAN PATHOLOGY
- Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
- (2009) Joaquim Bellmunt et al. JOURNAL OF CLINICAL ONCOLOGY
- Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
- (2009) Jason A. Efstathiou et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study of [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Staging of Muscle-Invasive Bladder Carcinoma
- (2009) Adam S. Kibel et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner
- (2009) E di Martino et al. ONCOGENE
- Surgery for Metastatic Urothelial Carcinoma with Curative Intent: The German Experience (AUO AB 30/05)
- (2008) Jan Lehmann et al. EUROPEAN UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now